5AM Opportunities I, L.P.

Track

Insider profile

Performance

Overall performance
3.6
Performance over holding periods
3.6
30 days 90 days 120 days
Average return 32% 8.2% 15.1%
Success rate 100% 68% 82%
Transactions
6 0% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
5AM Opportunities I, L.P.'s trades of Entrada Therapeutics Inc's stock


Subscribe to get access to the transaction volume chart and in-chart transaction details
• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Activity signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2025-07-09 2025-07-09
PrS Proposed sale
66,931
493.12
US$2,788,515 		66,931 493.12 US$2,788,515
2025-07-01 2025-07-01
PrS Proposed sale
59,371
139.64
US$119,080 		59,371 139.64 US$119,080
2025-06-27 2025-06-27
PrS Proposed sale
43,241
111.63
US$441,682 		43,241 111.63 US$441,682
2023-08-24 2023-08-24
PrS Proposed sale
72,876
17.01
US$1,239,621 		72,876 17.01 US$1,239,621
2022-06-07 2022-06-03
US Rallybio Corp (RLYB)
S Sale
99,671 -3.9%
12.50
US$1,245,888 		99,671 -3.9% 12.50 US$1,245,888
2022-06-07 2022-06-03
US Rallybio Corp (RLYB)
S Sale
50,329 -3.9%
12.50
US$629,112 		50,329 -3.9% 12.50 US$629,112
2022-05-25 2022-05-23
US Rallybio Corp (RLYB)
S Sale
66,447 -2.5%
13.00
US$863,811 		66,447 -2.5% 13.00 US$863,811
2022-05-25 2022-05-23
US Rallybio Corp (RLYB)
S Sale
33,553 -2.5%
13.00
US$436,189 		33,553 -2.5% 13.00 US$436,189
2022-02-10 2022-02-08
US Rallybio Corp (RLYB)
S Sale
139,539 -5.0%
13.05
US$1,820,984 		139,539 -5.0% 13.05 US$1,820,984
2022-02-10 2022-02-08
US Rallybio Corp (RLYB)
S Sale
70,461 -5.0%
13.05
US$919,516 		70,461 -5.0% 13.05 US$919,516
2021-08-04 2021-08-02
US Rallybio Corp (RLYB)
B Purchase
615,384 +77.8%
13.00
US$7,999,992 		615,384 +77.8% 13.00 US$7,999,992